Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02469961 · ClinicalTrials.gov registry record · Phase 4
Dexmedetomidine vs Propofol TIVA (Total Intravenous Anesthesia) and Interscalene Block
A Phase 4 study, sponsored by Maimonides Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT02469961 is a Phase 4 study that has completed, run by Maimonides Medical Center. The registered enrollment target is 50 participants.
The verdict
NCT02469961, a Phase 4 study, has completed, sponsored by Maimonides Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The standard hospital procedure calls for the patient to undergo Interscalene block under ultrasound with or without nerve stimulation guidance prior to going to operating room (OR). The block utilizes a 40 ml mixture of 0.5% Ropivacaine and Lidocaine 1.5%. At this time the patient receives preliminary sedation with Midazolam 1mg IV and Fentanyl 50 mcg IV. The participant is then brought to the OR and prolonged sedation is initiated, randomly using either Dexmedetomidine or Propofol. The primary objective of the present study is to use Dexmedetomidine for sedation, and compare the outcomes with Propofol sedation. The investigators will enroll 50 patients for this study. Our hypothesis is that Dexmedetomidine will cause fewer episodes of intermittent apnea, and reduced need for supplemental medication for sedation, compared to Propofol
Interventions
- DRUG Dexmedetomidine
- DRUG Propofol
- OTHER Interscalene block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02469961
The ClinicalTrials.gov registry entry for NCT02469961 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maimonides Medical Center, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dexmedetomidine is the first listed.
NCT02469961 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02469961 about?
NCT02469961 is a clinical study titled "Dexmedetomidine vs Propofol TIVA (Total Intravenous Anesthesia) and Interscalene Block". The standard hospital procedure calls for the patient to undergo Interscalene block under ultrasound with or without nerve stimulation guidance prior to going to operating room (OR). The block utilizes a 40 ml mixture of 0.5% Ropivacaine and Lidocaine 1.5%. At this time the patient receives prelimin...
What is the current status of trial NCT02469961?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2010-10. Estimated completion is 2012-07.
What interventions are being tested in trial NCT02469961?
The interventions under investigation include: Dexmedetomidine (DRUG), Propofol (DRUG), Interscalene block (OTHER).
Who is sponsoring clinical trial NCT02469961?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.